Transport and biotransformation of the new cytostatic complex cis- diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) by the rat liver

Journal of Lipid Research

Volumn 39, Issue 9, 1998, Pages 1792-1798

  Macias, Rocio I R ^a   Monte, Maria J ^a   El Mir, Mohamed Y ^a   Villanueva, Gloria R ^a   Marin, Jose J G ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bile acid; Cancer; Chemotherapy; Cisplatin; Glycocholate; Metal; Platinum (Pt)

Indexed keywords

BAMET R2; CISPLATIN; CISPLATIN DERIVATIVE; DIAMMINEPLATINUM(II) CHLOROCHOLYLGLYCINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE SECRETION; CONTROLLED STUDY; DRUG TARGETING; DRUG TRANSFORMATION; DRUG TRANSPORT; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BILE; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CISPLATIN; GLYCOCHOLIC ACID; KINETICS; LIVER; MALE; ORGANOPLATINUM COMPOUNDS; RATS; RATS, WISTAR;

EID: 0031682318     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ho, N. F. H. 1987. Utilizing bile acid carrier mechanisms to enhance liver and small intestine absorption. Ann. N. Y. Acad. Sci. 907: 315-329.
2. Betebenner, D. A., P. L. Carney, A. M. Zimmer, and J. M. Kazikiewicz. 1991. Hepatobiliary delivery of polyaminopolycarboxylate chelates: synthesis and characterization of a cholic acid conjugate of EDTA and biodistribution and imaging studies with its indium-111 chelate. Bioconjugale Chem. 2: 117-123.
3. Stephan, Z. F., E. C. Yurachek, R. Sharif, J. M. Wasvary, R. E. Steele, and C. Howes. 1992. Reduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid. Biochem. Pharmacol. 43: 1969-1974.
4. Kramer, W. and G. Wess. 1996. Bile acid transport systems as pharmaceutical targets. Eur. J. Clin. Invent. 26: 715-732.
5. Meijer, D. K. F. 1993. Drug targeting to the liver with bile acids - The Trojan Horse resurrected. Hepatology. 17: 945-948.
6. Kroker, R., M. S. Anwer, and D. Hegner. 1978. The lack of active bile acid transport in AS-30D ascites hepatoma cells. Naunyn Schmiedeberg's Arch. Pharmacol. 303: 299-301.
7. Von Dippe, P., and D. Levy. 1990. Expression of the bile acid transport protein during liver development and in hepatoma cells. J. Biol. Chem. 265: 5942-5945.
8. Marchegiano, P., F. Carubbi, C. Tiribelli, S. Amarri, M. Stebel, G. C. Lunazzi, D. Levy, and S. Bellentani. 1992. Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins. Biochem. Biophys. Res. Commun. 183: 1203-1208.
9. Kullak-Ublick, G. A., U. Beuers, and G. Paumgartner. 1996. Molecular and functional characterization of bile acid transport in human hepatoblastoma HcpG2 cells. Hepatology. 23: 1053-1060.
10. Criado, J. J., M. C. Herrera, M. F. Palomero, M. Medarde, E. Rodriguez, and J. J. G. Marin. 1997. Synthesis and characterization of a new bile acid and platinum(II) complex with cytostatic activity. J. Lipid Res. 38: 1022-1032.
11. Criado, J. J., R. I. R. Macias, M. Medarde, M. J. Monte, M. A. Serrano, and J. J. G. Marin. 1997. Synthesis and characterization of the new cytostatic complex cis-diammineplatinum(II) chlorocholylglycinate. Bioconjugate Chem. 8: 453-458.
12. Loeher, P. J., and L. H. Einhorn. 1984. Cisplatin. Ann. Int. Med. 100: 704-713.
13. Bradner, W. T., W. C. Rose, and J. B. Huftalen. 1980. Antitumor activity of platinum analogs. In Cisplatin: Current Status and New Developments. A.W. Prestayko, S.T. Crooke, and S.K. Carter, editors. Academic Press, New York. 171-182.
14. Christian, M. C. 1992. The current status of new platinum analogs. Sem. Oncol. 19: 720-733.
15. Maeda, M., N. Takasuka, T. Suga, and T. Sasaki. 1990. New antitumor platinum(II) complexes with both lipophilicity and water miscibility. Jpn. J. Cancer Res. 81: 567-569.
16. Maeda, M., T. Suga, N. Takasuka, A. Hoshi, and T. Sasaki. 1990. Effect of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes on lung metastasis of B16-F10 melanoma cells in mice. Cancer Lett. 55: 143-147.
17. Marin, J. J. G., M. C. Herrera, M. F. Palomero, R. I. R. Macias, M. J. Monte, M. Y. El-Mir, and G. R. Villanueva. 1998. Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum(II). J. Hepatol. 28: 417-425.
18. Berry, M. N., and D. S. Friend. 1969. High-yield preparation of isolated rat liver parenchymal cells. J. Cell Biol. 43: 506-520.
19. +-taurocholate cotransport and its encoding messenger RNA in primary cultures of rat hepatocytes. Hepatology. 18: 1162-1166.
20. Marin, J. J. G., A. Esteller, and G. R. Villanueva. 1988. Diabetes-induced cholestasis in the rat. Possible role of hyperglycemia and hypoinsulinemia. Hepatology. 8: 332-340.
21. Miller, L. L., C. G. Bly, M. L. Watson, and W. F. Bale. 1951. The dominant role of the liver in plasma protein synthesis. J. Exp. Med. 94: 431-445.
22. Markwell, M. A. K., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
23. Marin, J. J. G., M. C. Herrera, M. F. Palomero, R. I. R. Macias, M. J. Monte, G. R. Villanueva, M. Y. El-Mir, M. A Serrano, and J. J. Criado. 1996. In vivo distribution, toxicity and cytostatic capacity of platinated bile acid analogs. [Abstract] Hepatology. 24: 372A.
24. Hagcnbuch, B. and P. J. Meier. 1996. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin. Liver Dis. 16: 129-136.
25. Chu, G. 1994. Cellular responses to cisplatin - the roles of DNA-binding proteins and DNA repair. J. Biol. Chem. 269: 787-790.
26. Marin, J. J. G., J. J. Criado, M. F. Palomero, M. C. Herrera, R. I. R. Macias, M. J. Monte, G. R. Villanueva, M. Y. El-Mir, and M. A. Serrano. 1996. Platinated bile acids as cytostatic drugs. [Abstract] Hepatology. 24: 542A.
27. Ishikawa, T., and F. Ali-Osman. 1993. Glutathione-associated cis-diammine dichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J. Biol. Chem. 268: 20116-20125.
28. Taniguchi, K., M. Wada, K. Kohno, T. Nakamura, T. Kawabe, M. Kawakami, K. Kagotani, K. Okumura, S. Akiyama, and M. Kuwano. 1996. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 56: 4124-4129.
29. Muller, M., and P. L. M. Jansen. 1997. Molecular aspects of hepatobiliary transport. Am. J. Physiol. 35: G1285-G1303.
30. Gatmaitan, Z. C., and I. M. Arias. 1995. ATP-dependent transport systems in the canalicular membrane of the hepatocyte. Physiol. Rev. 75: 261-275.
31. Mazzanti, R., O. Fantappie, Y. Kamimoto, Z. C. Gatmaitan, P. Gentilini, and I. M. Arias. 1994. Bile acid inhibition of P-glycoprotein-mediated transport in multidrug-resistant cells and rat liver canalicular membrane vesicles. Hepatology. 20: 170-176.